To treat depression, EA can inhibit hyperexcitability of the HPA axis, decrease levels of inflammatory cytokines, enhance BDNF expression, restore hippocampal synaptic plasticity, regulate neuropeptides and neurotransmitters bidirectionally, and stimulate signal transduction pathways and genomic expression (78). The gene discussed is BDNF; the disease is depressive symptom measurement.